AVITA Medical (RCEL) EBT Growth (3y) (2021 - 2026)
AVITA Medical (RCEL) EBT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -2.34% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 20.27% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 35.51% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 23.63% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 25.85% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 6.73% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 89.20% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 17.92% |
| 10 | AVITA Medical | 309.50 Mn | 298.36 Mn | 17.77 Mn | 9.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.72% |
| Dec 31, 2025 | -36.49% |
| Sep 30, 2025 | -33.12% |
| Mar 31, 2025 | -13.56% |
| Sep 30, 2024 | 0.82% |
| Jun 30, 2024 | -12.81% |
| Mar 31, 2024 | -45.99% |
| Dec 31, 2023 | -7.80% |
| Sep 30, 2023 | 5.21% |
| Jun 30, 2023 | 7.04% |
| Mar 31, 2023 | 15.16% |
| Dec 31, 2022 | 59.28% |
| Sep 30, 2022 | -16.12% |
| Mar 31, 2022 | -15.23% |
| Sep 30, 2021 | -49.03% |